227 related articles for article (PubMed ID: 9721807)
1. Glucocorticoids inhibit activation-dependent expression of costimulatory molecule B7-1 in human monocytes.
Girndt M; Sester U; Kaul H; Hünger F; Köhler H
Transplantation; 1998 Aug; 66(3):370-5. PubMed ID: 9721807
[TBL] [Abstract][Full Text] [Related]
2. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.
Fleischer J; Soeth E; Reiling N; Grage-Griebenow E; Flad HD; Ernst M
Immunology; 1996 Dec; 89(4):592-8. PubMed ID: 9014827
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of B7-1 (CD80) and B7-2 (CD86) costimulatory molecules and dendritic cells on the immune response in leprosy.
Santos DO; Santos SL; Esquenazi D; Nery JA; Defruyt M; Lorré K; Van Heuverswyn H
Nihon Hansenbyo Gakkai Zasshi; 2001 Feb; 70(1):15-24. PubMed ID: 11244783
[TBL] [Abstract][Full Text] [Related]
4. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
5. Blocking B7 and CD40 co-stimulatory molecules decreases antiviral T cell activity.
Vermeiren J; Ceuppens JL; Haegel-Kronenberger H; De Boer M; Boon L; Van Gool SW
Clin Exp Immunol; 2004 Feb; 135(2):253-8. PubMed ID: 14738453
[TBL] [Abstract][Full Text] [Related]
6. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity.
Barcy S; Wettendorff M; Leo O; Urbain J; Kruger M; Ceuppens JL; de Boer M
Int Immunol; 1995 Feb; 7(2):179-89. PubMed ID: 7537534
[TBL] [Abstract][Full Text] [Related]
7. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity.
Fujihara M; Takahashi TA; Azuma M; Ogiso C; Maekawa TL; Yagita H; Okumura K; Sekiguchi S
Blood; 1996 Mar; 87(6):2386-93. PubMed ID: 8630402
[TBL] [Abstract][Full Text] [Related]
8. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of B7 expression by herpes simplex virus antigen.
Singh R; Kumar A; Diaz-Mitoma F
Hum Immunol; 2003 Aug; 64(8):780-6. PubMed ID: 12878356
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production.
Soos JM; Ashley TA; Morrow J; Patarroyo JC; Szente BE; Zamvil SS
Int Immunol; 1999 Jul; 11(7):1169-79. PubMed ID: 10383950
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes.
Clavreul A; D'hellencourt CL; Montero-Menei C; Potron G; Couez D
Immunology; 1998 Oct; 95(2):272-7. PubMed ID: 9824486
[TBL] [Abstract][Full Text] [Related]
12. Effect of factor VIII concentrate on antigen-presenting cell (APC)/T-cell interactions in vitro: relevance to inhibitor formation and tolerance induction.
Hodge G; Han P
Br J Haematol; 2000 Apr; 109(1):195-200. PubMed ID: 10848800
[TBL] [Abstract][Full Text] [Related]
13. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
Moosig F; Csernok E; Wang G; Gross WL
Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
[TBL] [Abstract][Full Text] [Related]
14. Mitogenic stimulation of T cells reveals differing contributions for B7-1 (CD80) and B7-2 (CD86) costimulation.
Perrin PJ; Davis TA; Smoot DS; Abe R; June CH; Lee KP
Immunology; 1997 Apr; 90(4):534-42. PubMed ID: 9176106
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD26/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs.
Ohnuma K; Munakata Y; Ishii T; Iwata S; Kobayashi S; Hosono O; Kawasaki H; Dang NH; Morimoto C
J Immunol; 2001 Dec; 167(12):6745-55. PubMed ID: 11739489
[TBL] [Abstract][Full Text] [Related]
16. Lack of B7-1/BB1 and B7-2/B70 expression on thyrocytes of patients with Graves' disease. Delivery of costimulatory signals from bystander professional antigen-presenting cells.
Matsuoka N; Eguchi K; Kawakami A; Tsuboi M; Nakamura H; Kimura H; Ishikawa N; Ito K; Nagataki S
J Clin Endocrinol Metab; 1996 Nov; 81(11):4137-43. PubMed ID: 8923872
[TBL] [Abstract][Full Text] [Related]
17. Prevention of primary T-cell responses by immunotoxins directed against CD80 and CD86.
Otten HG; Vooijs WC; van der Gouw AP; de Boer M; de Gast GC
Transplant Proc; 1997; 29(1-2):1034-5. PubMed ID: 9123185
[No Abstract] [Full Text] [Related]
18. Regulation of self-tolerance by CD80/CD86 interactions.
Lu P; Wang YL; Linsley PS
Curr Opin Immunol; 1997 Dec; 9(6):858-62. PubMed ID: 9492990
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of the costimulatory molecules B7-1 (CD80) and B7-2 (CD86) in an in vitro model of the human blood--brain barrier.
Omari KI; Dorovini-Zis K
J Neuroimmunol; 2001 Feb; 113(1):129-141. PubMed ID: 11137584
[TBL] [Abstract][Full Text] [Related]
20. B7-mediated costimulation and the immune response.
Schultze J; Nadler LM; Gribben JG
Blood Rev; 1996 Jun; 10(2):111-27. PubMed ID: 8813343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
